UnitedHealth Group Incorporated which can be found using ticker (UNH) have now 23 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between $675.00 and $480.00 and has a mean share price target at $592.09. (at the time of writing). Given that the stocks previous close was at $542.03 this would imply there is now a potential upside of 9.2%. The 50 day MA is $536.41 and the 200 day MA is $504.07. The company has a market capitalization of 504.47B. The stock price is currently at: $545.42 USD
The potential market cap would be $551,063,894,385 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 23.53, revenue per share of $386.66 and a 7.51% return on assets.
UnitedHealth Group Incorporated is a diversified health care company that operates Optum and UnitedHealthcare platforms. Its segments include Optum Health, Optum Insight, Optum Rx and UnitedHealthcare. Optum Health segment is focused on care delivery, care management, wellness and consumer engagement, and health financial services. Optum Insight segment serves the needs of hospital systems, physicians, health plans, governments and life sciences companies. Optum Rx segment offers pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, purchasing and clinical capabilities, and develops programs in areas such as step therapy, formulary management, drug adherence and disease/drug therapy management. UnitedHealthcare includes the combined results of operations of UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State and UnitedHealthcare Global.
